Neuroprotection by a caspase inhibitor in acute bacterial meningitis.
about
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitisPneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniaeRole of microglia in central nervous system infectionsPathophysiology and treatment of bacterial meningitisErythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathwaysCrystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathwayHost-pathogen interactions in bacterial meningitisPneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitisBacterial Peptidoglycan Transverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal BehaviorTriptans reduce the inflammatory response in bacterial meningitis.Preparation of Purified Gram-positive Bacterial Cell Wall and Detection in Placenta and Fetal TissuesThe p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsisThe apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal diseaseStaphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.Neuroprotection by caspase inhibitors.Characterization of a pneumococcal meningitis mouse modelApoptosis and its clinical impact.Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function.The trigeminovascular system in bacterial meningitis.Functional decline in aging and disease: a role for apoptosis.Experimental and emerging therapies for sepsis and septic shock.Revisiting caspases in sepsis.Cell wall-mediated neuronal damage in early sepsisInflammasome activation mediates inflammation and outcome in humans and mice with pneumococcal meningitis.HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells.MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activityRecent developments in the treatment of sepsis.Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques.Reprogramming the host response in bacterial meningitis: how best to improve outcome?Poly (I:C) therapy decreases cerebral ischaemia/reperfusion injury via TLR3-mediated prevention of Fas/FADD interactionThe carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brainDeath is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis.Treatment and prevention strategies to combat pediatric pneumococcal meningitis.Prevention of lymphocyte apoptosis--a potential treatment of sepsis?Review: apoptotic mechanisms in bacterial infections of the central nervous system.Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage.Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain.Apoptosis and caspases regulate death and inflammation in sepsis.Prevention of lymphocyte cell death in sepsis improves survival in mice.The pneumococcus: epidemiology, microbiology, and pathogenesis
P2860
Q24531928-4AD9ABBA-DDD7-436A-8D94-1B72AF803FF7Q24548716-B6187896-D264-4095-AD5A-763F30BB1D25Q24563024-FB10B3D8-87DD-4172-865F-676EBCE3BEB9Q24628983-DF74DA87-1414-4930-9957-4076F215CADCQ27347504-F779D12B-FFF4-40BA-A733-3B434C02E463Q27641840-4E4C8B38-4953-412E-8ED7-E56070667252Q28077430-4C051FAC-DAD0-4700-B5D1-1F5DF5E893F2Q28568567-85346848-7395-453F-889D-A28DC994D93CQ30725714-3EB5E6AD-5E86-4059-950E-147E595CFCF8Q30842137-5BCE8A54-778D-464E-B54C-40A1CF28EF41Q33738356-4ABAB144-6C47-4A86-BD4C-923989E3D56AQ33784578-7F49AC59-DD77-4B3E-B262-1D3C3C7213E0Q34033179-C5750EE8-437B-4F7C-A4A2-C5B1DE947290Q34097530-5AA6CC18-87C0-4A3B-BBE9-AE77E3ADF650Q34119497-3F7CB930-D86D-4A50-8742-5573CA5A26BCQ34210804-C1AC2362-DDF7-4531-B71F-C4B19315B722Q34214558-2566B6B1-7942-423F-B3ED-28DA9182FF81Q34215330-D3FDD9D3-DF8D-49BD-88F1-DC90BC7B03F1Q34218327-08A309E6-DD1A-4553-B6AE-0266D36EC3FFQ34370867-064EDCB9-27DE-4567-9AB6-9D593199CEC2Q34481636-C2B0F745-6023-406C-A4B1-A17AAD5585CCQ34662282-6A632160-F650-458E-8DD2-3BB082C535B2Q34721266-C9174F49-6A56-48D0-8C4A-27D90684C287Q34884374-BA4D12CD-2822-4217-8289-9269DE682729Q35009887-AF7659A1-1BC9-44EF-BEC1-F51A6BC1A759Q35045715-6C5E1E52-77E3-4160-AAC6-7834AF6F9733Q35056046-F74B8CA2-3F00-44F6-8466-4414BE8A8485Q35169397-4D0BB22E-8A1B-41A5-848C-020FA27A9A48Q35176266-A805E596-3E7A-4A66-B87A-EF850445659DQ35206508-532A9914-082A-49E6-9CEA-F44E5C1D1647Q35845628-463EFA4A-2F06-4632-B1BB-924F575C2301Q35852431-3CC433F8-1B40-481B-94E5-698314D0E351Q36278050-C150CC62-74C3-4643-969D-CC68821F1B9CQ36291734-7707EE7F-4C07-49FB-896E-D8643158A085Q36296389-E9719899-51B1-4598-8D3C-3A51FFD4F810Q36371540-8CD58798-E053-413B-AE22-278B29A37339Q36403935-CB1631D9-5592-47F9-8D29-5B32A1C66F99Q36622618-C323F188-145F-4157-8EF4-996EB4DCC3DFQ36748242-18301C4A-5ADB-4936-BDC7-1C85873E5877Q36938477-3925692D-3E15-4964-A33B-8B0189354FFA
P2860
Neuroprotection by a caspase inhibitor in acute bacterial meningitis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Neuroprotection by a caspase inhibitor in acute bacterial meningitis.
@en
type
label
Neuroprotection by a caspase inhibitor in acute bacterial meningitis.
@en
prefLabel
Neuroprotection by a caspase inhibitor in acute bacterial meningitis.
@en
P2093
P356
P1433
P1476
Neuroprotection by a caspase inhibitor in acute bacterial meningitis.
@en
P2093
P2888
P304
P356
10.1038/6514
P407
P577
1999-03-01T00:00:00Z